Table 1.
Baseline features of included patients.
| Total (N = 666) | Intervention group (N = 333) | Control group (N = 333) | P value | |
|---|---|---|---|---|
| Age, years | 58.3 ± 7.7 | 57.4 ± 7.7 | 59.2 ± 7.6 | <0.01 |
| Male sex | 550 (82.6%) | 279 (83.8%) | 271 (81.4%) | 0.47 |
| Home BP measurements | 232 (34.8%) | 122 (36.6%) | 110 (33.0%) | 0.37 |
| Antihypertensive medications | 330 (49.5%) | 165 (49.5%) | 165 (49.5%) | >0.99 |
| Diabetes | 200 (30.0%) | 92 (27.6%) | 108 (32.4%) | 0.15 |
| History of myocardial infarction | 111 (16.7%) | 52 (15.6%) | 59 (17.7%) | 0.53 |
| History of unstable angina | 46 (6.9%) | 25 (7.5%) | 21 (6.3%) | 0.35 |
| History of coronary revascularization | 648 (97.3%) | 321 (96.4%) | 327 (98.2%) | 0.23 |
| Total cholesterol (mg/dL) | 141.8 ± 30.4 (666) | 141.9 ± 28.3 (333) | 141.8 ± 32.4 (333) | 0.95 |
| HDL cholesterol (mg/dL) | 45.9 ± 11.4 (663) | 46.5 ± 11.8 (332) | 45.3 ± 10.9 (331) | 0.11 |
| LDL cholesterol (mg/dL) | 81.4 ± 23.0 (660) | 81.6 ± 22.4 (330) | 81.1 ± 23.7 (330) | 0.82 |
| Systolic blood pressure (mmHg) | 124.7 ± 16.4 (666) | 124.6 ± 16.1 (333) | 124.8 ± 16.7 (333) | 0.89 |
| Diastolic blood pressure (mmHg) | 75.1 ± 10.8 (666) | 75.4 ± 10.4 (333) | 74.8 ± 11.2 (333) | 0.49 |
| Body mass index (kg/m2) | 25.0 ± 3.2 (666) | 25.5 ± 3.3 (333) | 25.2 ± 3.1 (333) | 0.28 |
| Cigarette smoking | 161 (24.2%) | 66 (19.8%) | 95 (28.8%) | <0.01 |
| Predicted 10-year ASCVD risk (%)** | 10.1 (5.5‒16.1) | 9.5 (5.1‒15.3) | 10.8 (5.8‒16.8) | 0.01 |
*Mean ± SD (available number of subjects) for continuous variables, and n (%) for binary variables. **Median (interquartile ranges).
BP blood pressure, HDL high-density lipoprotein, LDL low-density lipoprotein, ASCVD atherosclerotic cardiovascular disease.